UNSPSC 51173222: Casanthranol/docusate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA209. This VA Drug Class (GA209) classifies this compound as belonging to the group LAXATIVES, OTHER.

UNSPSC 51173222 Casanthranol/docusate is a Commodity code that in state and local procurement typically maps to pharmaceutical products and related testing supplies. However, the recent solicitation activity under this code shows a significant mismatch: Collin County Community Supervision and Corrections Department in Texas posted an RFP for offender specimen collection and drug testing services, which encompasses lab-based immunoassay screening, confirmatory testing via LC/MS/MS or GC/MS, and alternative testing methodologies including oral fluid and hair analysis—services and infrastructure rather than the pharmaceutical product the code nominally describes. The scope includes staffing two collection sites in the Dallas-Fort Worth region (Plano and McKinney), operating an Interactive Voice Response system for randomized testing notifications, and electronic result reporting, with annual testing demand of approximately 25,031 tests across five-panel and six-panel screens plus ancillary testing. The solicitation reveals limited direct relevance to the casanthranol/docusate commodity category itself; the work being bought is forensic and clinical laboratory services for criminal justice compliance, not pharmaceutical procurement.

Collin County Community Supervision and Corrections Department is the sole issuing body reflected in the recent opportunities block. The RFP 2026-327 carries an estimated contract value of $600,000 over an initial two-year term commencing September 1, 2026, with three optional one-year renewal periods not to exceed five years total. Pricing is structured per test with three service models (screening only, confirmation after screening, and screening with automatic confirmation of positives), and the successful vendor must hold lab certification from SAMHSA, TX DPS, or CAP. The anticipated award date is August 10, 2026. The code shows little activity clearly aligned with pharmaceutical casanthranol/docusate procurement in state and local markets; the single recent opportunity tagged under it represents laboratory services delivery rather than chemical or pharmaceutical products.